Acrylic lenses produce virtually no PCO
The new acrylic *Acri.Lyc 356 (*Acri.Tec) diffractive intraocular lens (IOL) produces practically no posterior capsule opacification (PCO) compared with its silicone counterpart.
The new acrylic *Acri.Lyc 356 (*Acri.Tec) diffractive intraocular lens (IOL) produces practically no posterior capsule opacification (PCO) compared with its silicone counterpart, according to Filippo Simona from the LaserVis Refractive Centre, Locarno, Switzerland.
In a prospective, non-randomized pilot study, 116 eyes of 78 patients with senile cataract underwent phacoemulsification and implantation of the acylic *Acri.Lyc 356 (35 eyes) or the silicone *Acri.Tec 737 (81 eyes).
The results showed that both lenses provided both good near and distance visual acuity, however, the acrylic lens produced hardly any PCO, just 1% compared with 14% in the silicone group.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
